Singapore markets close in 50 minutes

  • Straits Times Index

    3,223.21
    +16.22 (+0.51%)
     

  • Nikkei

    31,857.62
    -14.90 (-0.05%)
     

  • Hang Seng

    17,818.54
    +445.51 (+2.56%)
     

  • FTSE 100

    7,646.12
    +44.27 (+0.58%)
     

  • Bitcoin USD

    27,140.61
    +709.10 (+2.68%)
     

  • CMC Crypto 200

    584.49
    +19.70 (+3.49%)
     

  • S&P 500

    4,299.70
    +25.19 (+0.59%)
     

  • Dow

    33,666.34
    +116.07 (+0.35%)
     

  • Nasdaq

    13,201.28
    +108.43 (+0.83%)
     

  • Gold

    1,890.30
    +11.70 (+0.62%)
     

  • Crude Oil

    91.71
    0.00 (0.00%)
     

  • 10-Yr Bond

    4.5970
    0.0000 (0.00%)
     

  • FTSE Bursa Malaysia

    1,426.14
    -13.97 (-0.97%)
     

  • Jakarta Composite Index

    6,966.87
    +29.04 (+0.42%)
     

  • PSE Index

    6,321.24
    -64.28 (-1.01%)
     

HealthEquity (HQY) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks Equity Research
·2-min read

For the quarter ended April 2023, HealthEquity (HQY) reported revenue of $244.43 million, up 18.8% over the same period last year. EPS came in at $0.50, compared to $0.27 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $239.85 million, representing a surprise of +1.91%. The company delivered an EPS surprise of +21.95%, with the consensus EPS estimate being $0.41.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how HealthEquity performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Total HSA Assets: $22.32 billion versus the three-analyst average estimate of $23.30 billion.

  • Total HSA investments: $8.21 billion compared to the $8.57 billion average estimate based on three analysts.

  • HSAs Accounts: 8.05 million versus the three-analyst average estimate of 8.03 million.

  • Total Accounts: 14999 thousand compared to the 15120.22 thousand average estimate based on two analysts.

  • Total HSA cash: $14.11 billion compared to the $14.98 billion average estimate based on two analysts.

  • Revenue- Service revenue: $105.11 million compared to the $111.11 million average estimate based on four analysts. The reported number represents a change of +0.7% year over year.

  • Revenue- Custodial revenue: $94.44 million versus the four-analyst average estimate of $85.42 million. The reported number represents a year-over-year change of +59.1%.

  • Revenue- Interchange revenue: $44.88 million versus the four-analyst average estimate of $44.72 million. The reported number represents a year-over-year change of +6.9%.

View all Key Company Metrics for HealthEquity here>>>

Shares of HealthEquity have returned +8.2% over the past month versus the Zacks S&P 500 composite's +4.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

HealthEquity, Inc. (HQY) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research